ASPC 2018 Congress on CVD Prevention

 

ASPC 2018 Congress on CVD Prevention
Avatar

Differentiating Antiplatelet Agents

By ASPC 2018 Congress on CVD Prevention FEATURING Peter Toth
By ASPC 2018 Congress on CVD Prevention FEATURING Peter Toth
0 views
August 10, 2018
Comments 0
Login to view comments. Click here to Login

Featured Video

15:01
Lilly Diabetes

Discover the MOA of an Incretin Medication for T2D

Featured Video

26:13
Lilly Diabetes

A Journey through Five Phase 3 Clinical Trials for a T2D Incretin Me…

Feat. B. Hirsch
SESSION 3 - Cardiometabolic
28:08
ASPC 2018 Congress on CVD Prevention

Role of SGLT2/GLP1 Agents in a Preventive Cardiologist’s Practice, a…

Feat. M. Kosiborod
24:44
ASPC 2018 Congress on CVD Prevention

Comprehensive Approach to Lowering CVD Risk in Diabetics

Feat. Y. Handelsman
23:46
ASPC 2018 Congress on CVD Prevention

Differentiating Antiplatelet Agents

Feat. P. Toth
18:12
ASPC 2018 Congress on CVD Prevention

SESSION 3 - Cardiometabolic Discussion